论文部分内容阅读
目的:研究分析贝特类和他汀类降脂药物联合应用对社区内糖尿病患者视网膜病变的防治效果及护理方法。方法:将2013年12月至2014年11月社区内54例糖尿病患者视网膜病变患者为研究对象,根据自愿原则将患者分组并采用不同方式进行防治护理,并对评价指标进行统计对比分析。结果:采用特类和他汀类降脂药物联合使用及采用针对性护理的观察组的三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、空腹血糖(FBG)指标值显著优于采用他汀类降脂药物进行治疗并采用常规方式护理的对照组,差异具有统计学意义(P<0.05);两组患者治疗后的视网膜病变症状明显好转,较治疗前比较,差异具有统计学意义(P<0.05),观察组比对照组好转明显,差异具有统计学意义(P<0.05)。结论:采用贝特类联合他汀类降脂药物并采用针对性护理可显著改善患者的血脂指标值,并使患者的病变症状得到有效控制和改善,具有较高的治疗用药价值。
OBJECTIVE: To study the preventive and therapeutic effects of combination of fibrates and statins lipid-lowering drugs on diabetic retinopathy in community and nursing methods. Methods: From December 2013 to November 2014, 54 patients with diabetic retinopathy were enrolled in this study. Patients were divided into groups according to the principle of voluntariness and adopted different ways to prevent and treat them. Statistical analysis was made on the evaluation indexes. Results: The triglyceride (TG), high density lipoprotein cholesterol (HDL-C) and fasting blood glucose (FBG) values of the observation group treated with special class and statin lipid-lowering drugs in combination with targeted care were significantly better than those of the control group The difference was statistically significant (P <0.05). The symptoms of retinopathy in both groups were significantly improved after treatment compared with before treatment, the difference was statistically significant (P <0.05). The observation group improved more obviously than the control group, the difference was statistically significant (P <0.05). Conclusion: The combined use of fibrates and statins lipid-lowering drugs and targeted care can significantly improve the patient’s blood lipid index values, and the patient’s disease symptoms are effectively controlled and improved, with a higher therapeutic value.